The Nicotine Replacement Therapy Market is projected to experience steady growth, with its valuation rising from USD 2.83 billion in 2023 to an estimated USD 4.27 billion by 2032, at a CAGR of 4.83% over the forecast period of 2024 to 2032. This growth is attributed to increasing awareness about the health risks of smoking, supportive government initiatives, and the rising availability of innova..